About this event

  • Date and time Tue 20 Oct 2020 from 1:00pm to 2:05pm
  • Location Online
  • Organised by Digital Health

Explore the concept of personalised care, and the role of digital technology in delivering these services, in this brand new Digital Health webinar series. 

In this first episode, join us for an overview of the range of opportunities to develop personalised services for health and care, as we examine the role of digital services as an enabler for these services. We will look at the role of genomics to drive personalised services and how clinical trials could look in the future.

Join in the conversation online using #RSMDigiHealth
Follow us on Twitter: @RoySocMed

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.

This webinar is a part of a series, Personalised Medicine, that will be broadcast weekly on Tuesday afternoons at 1:00pm. If you would like to find out more about the series, please visit the Digital Health Section homepage.

Key speakers

David Champeaux

David Champeaux

Chief Growth Officer, Cherish Health, Advisory Council, HIMSS International, Non-Executive Director, LiveBetterWith Healthcare Affiliate Partner, IPsoft

Speaker's biography

David Champeaux is a digital entrepreneur and advisor to health systems and health technology innovators, focused on transforming health and care delivery and payment models, sustainably and at scale. His digital entrepreneurship experience, gained across multiple industries ranging from the global logistics industry to SaaS for enterprise mobility, has focused on designing innovation into the lives of people - both customers and service providers - and into the commercial, regulatory and process fabric of complex networked ecosystems. As a Partner at McKinsey and then Accenture, and later as healthcare business lead for IPsoft, a cognitive AI platform provider, David translated these insights into healthcare ecosystems across the world, from the UK and Europe to Singapore and Australia, working with payors and providers, and innovators from within the health ecosystem as well as new entrants, on designing and driving sustainable adoption of digital-enabled innovations, at scale. 

 

David Champeaux is now the Chief Growth Officer for Cherish Health, where he is leading its international development, as well as engagement with relevant ecosystem partners who extend and complement Cherish Health’s solutions with relevant content, services and products. David also serves on the Advisory Council for HIMSS in Europe, is a non-executive board member for LiveBetterWith, a UK healthcare community helping people cope with specific chronic conditions, and is a Healthcare Affiliate Partner for IPsoft, advising on the development of AI-enabled conversational agents in health and care.

Bill Newman

Professor Bill Newman

Professor of Translational Genomic Medicine, The Manchester Centre for Genomic Medicine, University of Manchester

Speaker's biography

Professor Bill Newman is a clinician scientist. He studied Medicine at Manchester University and completed professional training in adult medicine in the North West of England. He started training in Clinical Genetics in 1995 and undertook a PhD as a Wellcome Trust Clinical Training Fellow on the genetics of bone development and osteoarthritis in the Wellcome Trust Cell Matrix Centre. He moved to Toronto to undertake a two-year Arthritis Society Fellowship with Professor Kathy Siminovitch where he worked on the genetic basis of rheumatoid arthritis and inflammatory bowel disease.

 

Professor Newman took up his post as Clinical Senior Lecturer in Genetics at the University of Manchester and Honorary Consultant at St Mary's Hospital in 2004 and was awarded Chair in 2013. His research focuses on pharmacogenetics - defining the genetic factors that influence how patients respond to their medications. He has an interest in rare diseases and has discovered a number of genes responsible for a range of conditions and complex mutational mechanisms that lead to these.

Glen de Vries

Glen de Vries

 Co-founder and co-CEO, Medidata Solutions

Speaker's biography

Glen de Vries is co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world. Medidata has powered tens of thousands of clinical trials, with millions of patients and billions of patient records. In 2019, in one of the largest health care technology acquisitions in history, Medidata became part of Dassault Systèmes. Glen has been driving Medidata’s mission since the company’s inception in 1999, “powering smarter treatments and healthier people” by advancing pharmaceutical business transformation with technology, non-traditional ways of thinking, and industry collaboration. Glen’s publications have appeared in Applied Clinical Trials, Cancer, The Journal of Urology, Molecular Diagnostics, and other journals. He serves as a trustee of Carnegie Mellon University and is the author of The Patient Equation (de Vries & Blachman, 2020).


Glen received his undergraduate degree in molecular biology and genetics from Carnegie Mellon University, worked as a research scientist at the Columbia Presbyterian Medical Center and studied computer science at New York University's Courant Institute of Mathematics.

Agenda

View the programme here

Welcome and introduction

Dr Tim Ringrose, President Elect, Digital Health Council, Royal Society of Medicine

Three dimensions of personalisation: Medical, behavioural, contextual

Mr David Champeaux, Chief Growth Officer, Cherish Health

The point of genetic care tests in personalised medicine

Professor Bill Newman, Professor of Translational Genomic Medicine, The Manchester Centre for Genomic Medicine, University of Manchester

Glen de Vries, Co-Founder and Co-CEO, Medidata Solutions

Panel discussion

Chair: Dr Tim Ringrose

Close of meeting

Location

Online

Disclaimer:All views expressed in this webinar are of the speakers themselves and not of the RSM nor the speaker's organisations. 

Special rates for difficult times 
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s COVID-19 online events are available free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic. 

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.

All webinars will be available for registered delegates 30 days after on Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels. 

Man searching computer

Join the RSM and get unlimited digital learning and e-resources access

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy unlimited digital learning any time you need and access to e-journals, e-books and 7 huge medical databases to support your clinical decision-making and research.

Our e-resources are updated continuously to ensure you receive the cutting edge knowledge you need. 

 

Become a member